THOROLD, ON, Oct. 5, 2011 /PRNewswire/ - Norgen Biotek Corp.,an innovative Canadian biotechnology company focusing principally on
advancing powerful innovations for nucleic acid and protein
preservation and purification from all type of specimens for research
and molecular diagnostic applications, today announced successful
accreditation to ISO 15189:2007 by the Standards Council of Canada
(SCC). This ISO accreditation emphasizes our commitment to quality in
our laboratory and R&D services. Norgen's scope of accreditation for
ISO 15189 will allow the company to provide high quality, competent
molecular diagnostic testing for research purposes and clinical
trials. Moreover, this ISO certification will be a great benefit to
Norgen in obtaining regulatory approval for our various in vitro
molecular diagnostic kits which are currently marketed for research
This new ISO 15189:2007 accreditation will complement Norgen's current
quality certifications to ISO 9001:2008 as well as ISO 13485:2003. ISO
9001:2008 certification indicates our continuing commitment to our
quality management system, while certification to ISO 13485 is a
requirement for the manufacturing of commercial medical devices
including in vitro diagnostic kits. Certification to all three of
these ISO standards strengthens Norgen's commitment to uphold the
highest quality in manufacturing our best-in-class products for sample
preparation as well as our commitment to providing highly competent R&D
and diagnostic testing services.
"Currently, we have over a 100 in vitro MDx kits for the detections of
all type of pathogens for research use. This latest ISO certification
(15189:2007) is critical for taking all of these kits through the
regulatory approval process. Also, this certification is a testimony
to the high quality products and services that we provide at Norgen
Biotek" said Dr. Yousef Haj-Ahmad, President & CEO of Norgen Biotek.
About Norgen Biotek Corp.
Norgen Biotek is a rapidly growing privately-held Canadian biotech
company committed to providing innovative products and services to the
life sciences and pharmaceutical industry. Norgen continues to develop
products for the purification and preservation of nucleic acids and
proteins from all types of specimens for applications in R&D as well as
in vitro molecular diagnostics. Detailed information about the company
is available at www.norgenbiotek.com.
SOURCE Norgen Biotek Corp.